Open-label Extension Study of ADP101

NCT05243719 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

45

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Food Allergy

Interventions

BIOLOGICAL: ADP101

Sponsor

Alladapt Immunotherapeutics, Inc.